Bloomia Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $67MTTM through 31 Mar 2026
Free Cash Flow -$8.6MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | -7.8% |
| Net Margin | -17.5% |
Balance Sheet Health
Debt / Equity6.66x
Current Ratio1.26x
Net Debt$39.5M
Cash & Equivalents$889K
Quality Metrics
FCF Margin-12.9%
Multi-Year Trend
RevenueFY2024: $37.8M
Diluted EPS-$3.92TTMFY2024: $-3.24
Dividend
148.48%Yield
Capital Allocation
R&D Spend$0
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Specialty Agriculture | $26.3M | +4.0% | View detailsThe company is focused on reducing leverage and lowering annual interest expense by utilizing rights offering proceeds to repay acquisition debt at a discount. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.